Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy.
Italian National Blood Centre, National Institute of Health, Rome, Italy.
Semin Thromb Hemost. 2017 Jul;43(5):525-529. doi: 10.1055/s-0037-1599143. Epub 2017 Mar 15.
In addition to their major role in transfusion medicine, there is increasing evidence that ABO blood group antigens (complex carbohydrate molecules widely expressed on the surface of red blood cells and several other cell types) are implicated in the development of a wide array of pathologic conditions. In particular, intense research has been dedicated over the last 50 years to the study of the association between non-O blood type and the risk of developing cardiovascular disorders. Several pathways have been hypothesized to explain this relationship, the most reasonable implying the influence of the ABO blood group on circulating plasma levels of von Willebrand factor, factor VIII, and several inflammatory cytokines. This narrative review summarizes the current knowledge on the role of ABO antigens in both venous and arterial thromboses, focusing on their association with clinical scoring systems evaluating thrombotic risk.
除了在输血医学中的主要作用外,越来越多的证据表明 ABO 血型抗原(广泛表达于红细胞和其他几种细胞表面的复杂碳水化合物分子)与多种病理状况的发展有关。特别是,在过去的 50 年中,人们对非 O 型血与心血管疾病风险之间的关联进行了大量研究。已经提出了几种途径来解释这种关系,最合理的解释是 ABO 血型对循环血浆中血管性血友病因子、因子 VIII 和几种炎症细胞因子水平的影响。本综述总结了 ABO 抗原在静脉和动脉血栓形成中的作用的最新知识,重点介绍了它们与评估血栓形成风险的临床评分系统的关联。